CAJ | 학술논문

国际妇产科联盟月经疾病组（FMDG）提出异常子宫出血（abnormal uterine bleeding，AUB）是涵盖月经紊乱的术语，应摒弃月经过多和功能失调性子宫出血（dysfunctional uferine bleading，DUB）称谓。月经量过多术语推荐用严重出血（heavy menstrual bleeding，HMB）替代月经过多。FMDG把AUB按照病因的首字母分为9个系统，即PALM-COEIN。其中COEIN为非器质性因素引起的AUB，首选为药物治疗，包括抗纤溶制剂、非甾体类抗炎药（NSAIDs）、避孕药、孕激素和左炔诺孕酮宫内缓释系统（LNG-IUS）等。LNG-IUS是最有效的治疗特发性HMB的方法之一，可以长期有效地控制月经量。去氨加压素（desmopressin，DDAVP）在治疗凝血功能障碍患者HMB时有效。二甲双胍可调节多囊卵巢综合征（PCOS）妇女月经，并对子宫内膜增生性疾病孕激素抵抗的患者有治疗作用。另外，四相口服避孕药、氨甲环酸的新制剂、丹那唑的阴道制剂和阴道避孕环等是治疗HMB的可供选择新方法。
국제부산과련맹월경질병조（FMDG）제출이상자궁출혈（abnormal uterine bleeding，AUB）시함개월경문란적술어，응병기월경과다화공능실조성자궁출혈（dysfunctional uferine bleading，DUB）칭위。월경량과다술어추천용엄중출혈（heavy menstrual bleeding，HMB）체대월경과다。FMDG파AUB안조병인적수자모분위9개계통，즉PALM-COEIN。기중COEIN위비기질성인소인기적AUB，수선위약물치료，포괄항섬용제제、비치체류항염약（NSAIDs）、피잉약、잉격소화좌결낙잉동궁내완석계통（LNG-IUS）등。LNG-IUS시최유효적치료특발성HMB적방법지일，가이장기유효지공제월경량。거안가압소（desmopressin，DDAVP）재치료응혈공능장애환자HMB시유효。이갑쌍고가조절다낭란소종합정（PCOS）부녀월경，병대자궁내막증생성질병잉격소저항적환자유치료작용。령외，사상구복피잉약、안갑배산적신제제、단나서적음도제제화음도피잉배등시치료HMB적가공선택신방법。
FIGO Menstrual Disorders Group (FMDG) put forward that the abnormal uterine bleeding(AUB) was a suitable overarching term for the symptom of disturbed menstrual bleeding,and that the terms’menorrhagia’ and ’disfunctional uterine bleeding (DUB)’ should be discarded . The heavy menstrual bleeding (HMB) should be used to replace the term of menorrhagia for the symptom of excess menstrual bleeding. FMDG classified the AUB according to the causes using the PALM-COEIN system. Medical management should be the initial treatment for AUB of COEIN causes, including multi-dose regimens of combined oral contraceptives or oral progestins,NSAIDs,tranexamic acid and the levonorgestrel-releasing intrauterine system (LNG-IUS). LNG-IUS is the most effective medical treatment for idiopathic HMB. Desmopressin is effective in management of HMB in women with bleeding disorders. Metformin is applied to regulate the menstrual cycle in PCOS women. And Metformin has therapeutical effect on the endometrial hyperplasia combined with progestin-resistant. Moreover, there are more choices for HMB treatment, such as the new four-phasic estradiol valerate/dienogest contraceptive pills, the modified-release formulation of tranexamic acid, the combined contraceptive vaginal ring, and vaginal danazol.